Researchers have generated immature human sperm cells from induced pluripotent stem cells, nurturing them to a stage resembling early development in the body. The advance, reported in a study published in Cell Stem Cell, offers fresh insight into the earliest phases of male reproduction and the roots of infertility that affect millions of couples.
The procedure began with human induced pluripotent stem cells converted into primordial germ cell-like cells. These were combined with non-reproductive support cells taken from mouse testicles and transplanted into a pouch on a living mouse kidney. After six months the human cells had progressed into spermatogonia, both undifferentiated and differentiated forms, along with preleptotene spermatocytes similar to those observed in natural development.
Yet the cells halted at an immature stage. They did not mature into functional sperm. This limitation is central to the findings. Kotaro Sasaki, developmental biologist at the University of Pennsylvania, noted the gap between species when he said: "In humans, the work is so behind."
The research team, led by Sasaki and Eoin Whelan, both developmental and reproductive biologists at the University of Pennsylvania, approached the project from a basic science perspective. Whelan made the position clear: "We are approaching this from a basic science perspective. We are a long way from clinical application." Their goal centres on mapping the mechanisms of early sperm formation and identifying causes of male infertility. Around 40 percent of such cases currently have no known origin.
Building on earlier efforts
This latest work extends previous research into in-vitro gametogenesis. Earlier studies succeeded in producing fertile sperm and eggs from mouse pluripotent stem cells that went on to create live offspring. Progress with human cells has lagged, largely because of significant differences in how germ cells develop across species. The new method used a xenogeneic reconstituted testis model, relying on mouse support cells to coax human cells further than prior laboratory techniques had achieved.
Such incremental gains matter. They illuminate biological processes that have remained opaque. At the same time they underscore the distance still to travel. Many technical hurdles remain before mature human sperm can be created reliably in the laboratory. Claims of imminent clinical use would outrun the evidence.
